Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
2.060
+0.090 (4.57%)
At close: Apr 1, 2025, 4:00 PM
1.993
-0.067 (-3.23%)
After-hours: Apr 1, 2025, 4:06 PM EDT

Intensity Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-16.27-10.54-7.58-7.9-6.03
Upgrade
Other Amortization
-0.16---
Upgrade
Asset Writedown & Restructuring Costs
0.030.150.180.170.12
Upgrade
Stock-Based Compensation
3.121.41.170.720.56
Upgrade
Other Operating Activities
-2.26---
Upgrade
Change in Accounts Payable
-2.271.630.7-0.05-0.17
Upgrade
Change in Other Net Operating Assets
0.17-2.260.050.230.16
Upgrade
Operating Cash Flow
-15.22-7.21-5.48-6.83-5.37
Upgrade
Investment in Securities
6.35-6.02--4.56
Upgrade
Investing Cash Flow
6.35-6.02--4.56
Upgrade
Short-Term Debt Issued
-0.232.252-
Upgrade
Total Debt Issued
-0.232.252-
Upgrade
Net Debt Issued (Repaid)
-0.232.252-
Upgrade
Issuance of Common Stock
3.5522.48-0.050.03
Upgrade
Other Financing Activities
-0.65-2.23---
Upgrade
Financing Cash Flow
2.920.472.252.056.29
Upgrade
Net Cash Flow
-5.977.24-3.23-4.785.49
Upgrade
Levered Free Cash Flow
-9.54-2.77-2.74-3.97-3.08
Upgrade
Unlevered Free Cash Flow
-9.54-2.74-2.69-3.97-3.08
Upgrade
Change in Net Working Capital
2.3-1.06-0.86-0.32-0.26
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q